Fresenius SE & Co. KGaA (FRE.DE)
EUR 34.19
(0.41%)
EUR 34.19
(0.41%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 22.29 Billion EUR | -45.4% |
| 2022 | 40.84 Billion EUR | 8.85% |
| 2021 | 37.52 Billion EUR | 3.43% |
| 2020 | 36.27 Billion EUR | 2.45% |
| 2019 | 35.4 Billion EUR | 5.6% |
| 2018 | 33.53 Billion EUR | -1.05% |
| 2017 | 33.88 Billion EUR | 16.51% |
| 2016 | 29.08 Billion EUR | 5.27% |
| 2015 | 27.62 Billion EUR | 18.92% |
| 2014 | 23.23 Billion EUR | 14.26% |
| 2013 | 20.33 Billion EUR | 5.4% |
| 2012 | 19.29 Billion EUR | 16.75% |
| 2011 | 16.52 Billion EUR | 3.44% |
| 2010 | 15.97 Billion EUR | 12.76% |
| 2009 | 14.16 Billion EUR | 14.82% |
| 2008 | 12.33 Billion EUR | 8.61% |
| 2007 | 11.35 Billion EUR | 5.39% |
| 2006 | 10.77 Billion EUR | 36.61% |
| 2005 | 7.88 Billion EUR | 8.5% |
| 2004 | 7.27 Billion EUR | 2.93% |
| 2003 | 7.06 Billion EUR | -5.9% |
| 2002 | 7.5 Billion EUR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 5.46 Billion EUR | -4.28% |
| 2024 Q1 | 5.7 Billion EUR | 0.46% |
| 2023 Q4 | 5.67 Billion EUR | 2.9% |
| 2023 FY | 22.29 Billion EUR | -45.4% |
| 2023 Q1 | 10.22 Billion EUR | -3.93% |
| 2023 Q2 | 10.35 Billion EUR | 1.31% |
| 2023 Q3 | 5.51 Billion EUR | -46.73% |
| 2022 Q3 | 10.45 Billion EUR | 4.4% |
| 2022 Q4 | 10.64 Billion EUR | 1.76% |
| 2022 FY | 40.84 Billion EUR | 8.85% |
| 2022 Q1 | 9.72 Billion EUR | -2.47% |
| 2022 Q2 | 10.01 Billion EUR | 3.07% |
| 2021 Q4 | 9.96 Billion EUR | 6.89% |
| 2021 Q2 | 9.24 Billion EUR | 2.92% |
| 2021 Q1 | 8.98 Billion EUR | -3.44% |
| 2021 Q3 | 9.32 Billion EUR | 0.84% |
| 2021 FY | 37.52 Billion EUR | 3.43% |
| 2020 Q4 | 9.3 Billion EUR | 4.33% |
| 2020 Q1 | 9.13 Billion EUR | -1.89% |
| 2020 Q2 | 8.92 Billion EUR | -2.35% |
| 2020 Q3 | 8.91 Billion EUR | -0.02% |
| 2020 FY | 36.27 Billion EUR | 2.45% |
| 2019 FY | 35.4 Billion EUR | 5.6% |
| 2019 Q1 | 8.49 Billion EUR | -3.85% |
| 2019 Q4 | 9.31 Billion EUR | 5.3% |
| 2019 Q3 | 8.84 Billion EUR | 0.92% |
| 2019 Q2 | 8.76 Billion EUR | 3.13% |
| 2018 Q3 | 8.19 Billion EUR | -2.27% |
| 2018 Q4 | 8.83 Billion EUR | 7.85% |
| 2018 FY | 33.53 Billion EUR | -1.05% |
| 2018 Q1 | 8.12 Billion EUR | -6.6% |
| 2018 Q2 | 8.38 Billion EUR | 3.21% |
| 2017 Q1 | 8.36 Billion EUR | 8.06% |
| 2017 Q4 | 8.69 Billion EUR | 4.8% |
| 2017 Q3 | 8.29 Billion EUR | -2.75% |
| 2017 FY | 33.88 Billion EUR | 16.51% |
| 2017 Q2 | 8.53 Billion EUR | 2.03% |
| 2016 Q4 | 7.73 Billion EUR | 5.44% |
| 2016 Q2 | 7.09 Billion EUR | 2.57% |
| 2016 Q1 | 6.91 Billion EUR | -4.73% |
| 2016 FY | 29.08 Billion EUR | 5.27% |
| 2016 Q3 | 7.33 Billion EUR | 3.48% |
| 2015 Q1 | 6.48 Billion EUR | -0.57% |
| 2015 FY | 27.62 Billion EUR | 18.92% |
| 2015 Q4 | 7.25 Billion EUR | 4.57% |
| 2015 Q3 | 6.94 Billion EUR | -0.09% |
| 2015 Q2 | 6.94 Billion EUR | 7.14% |
| 2014 FY | 23.23 Billion EUR | 14.26% |
| 2014 Q2 | 5.52 Billion EUR | 5.93% |
| 2014 Q3 | 5.97 Billion EUR | 8.28% |
| 2014 Q4 | 6.52 Billion EUR | 9.07% |
| 2014 Q1 | 5.21 Billion EUR | -1.64% |
| 2013 Q2 | 5.09 Billion EUR | 4.23% |
| 2013 Q3 | 5.04 Billion EUR | -1.02% |
| 2013 Q4 | 5.29 Billion EUR | 5.03% |
| 2013 FY | 20.33 Billion EUR | 5.4% |
| 2013 Q1 | 4.89 Billion EUR | -5.78% |
| 2012 Q4 | 5.19 Billion EUR | 6.7% |
| 2012 FY | 19.29 Billion EUR | 16.75% |
| 2012 Q2 | 4.81 Billion EUR | 9.01% |
| 2012 Q1 | 4.41 Billion EUR | -0.32% |
| 2012 Q3 | 4.86 Billion EUR | 0.98% |
| 2011 Q3 | 4.08 Billion EUR | 1.06% |
| 2011 Q4 | 4.43 Billion EUR | 8.52% |
| 2011 FY | 16.52 Billion EUR | 3.44% |
| 2011 Q2 | 4.04 Billion EUR | 2.02% |
| 2011 Q1 | 3.96 Billion EUR | -4.55% |
| 2010 FY | 15.97 Billion EUR | 12.76% |
| 2010 Q4 | 4.15 Billion EUR | 0.39% |
| 2010 Q2 | 4.04 Billion EUR | 10.98% |
| 2010 Q1 | 3.64 Billion EUR | -2.46% |
| 2010 Q3 | 4.13 Billion EUR | 2.28% |
| 2009 Q3 | 3.53 Billion EUR | 0.34% |
| 2009 Q2 | 3.52 Billion EUR | 4.42% |
| 2009 Q1 | 3.37 Billion EUR | 0.0% |
| 2009 FY | 14.16 Billion EUR | 14.82% |
| 2009 Q4 | 3.73 Billion EUR | 5.69% |
| 2008 FY | 12.33 Billion EUR | 8.61% |
| 2007 FY | 11.35 Billion EUR | 5.39% |
| 2006 FY | 10.77 Billion EUR | 36.61% |
| 2005 FY | 7.88 Billion EUR | 8.5% |
| 2004 FY | 7.27 Billion EUR | 2.93% |
| 2003 FY | 7.06 Billion EUR | -5.9% |
| 2002 FY | 7.5 Billion EUR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Fresenius Medical Care AG & Co. KGaA | 19.45 Billion EUR | -14.626% |
| LIMES Schlosskliniken AG | 37.17 Million EUR | -59887.052% |
| M1 Kliniken AG | 316.31 Million EUR | -6949.538% |
| Maternus-Kliniken Aktiengesellschaft | 102.3 Million EUR | -21696.376% |
| MEDICLIN Aktiengesellschaft | 761.59 Million EUR | -2827.919% |
| RHÖN-KLINIKUM Aktiengesellschaft | 1.73 Billion EUR | -1185.449% |
| VITA 34 AG | 77.06 Million EUR | -28836.441% |